Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MilkBAT Performance of the Basophil Activation Test in the Diagnosis of IgE-mediated Cow's Milk Allergy in Infants and Evaluation of Hydrolysate Allergenicity.

NCT07900594 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07900594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
MilkBAT Performance of the Basophil Activation Test in the Diagnosis of IgE-mediated Cow's Milk Allergy in Infants and Evaluation of Hydrolysate Allergenicity.
Lead sponsor
Odense University Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 1, 2027
Completion date
December 31, 2029
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

milk allergy

Arms

As registered; 1 arm.

  • BAT ExperimentalBasophil activation test, quality of life questionnaire

    All included children will have a BAT-analysis that will be compared with the IgE measurement

Primary endpoints

Registered primary outcome measures; 1 primary.

  • The sensitivity and specificity of BAT from enrollment to the oral food provocation test, approximately 2-6 months

    To determine the performance of the BAT to predict the outcome of the Oral Food Challenge (reference standard) for children suspected of IgE-mediated CMA.

    The Oral Food challenge is the gold standard for diagnosing food allergy. It is a dichotomous variable (positive or negative).

    The sensitivity and the specificity of the BAT alone and BAT in combination with IgE will be calculated.

Lead sponsor's other trials

Odense University Hospital, most recent start first.

Similar trials

Same condition (Milk Hypersensitivity) and phase, most recent start first.